Single digits have wide margin. Mid point would be 5. Just saying. Sarcasm aside, co definitely needs money at some point prior to launch and partnership is no where in sight. It could be big pharma is waiting on the labeling upon approval. Without that label, Daxi is another Botox wannabe, IMO.